Search Results - "Anne Blaes"

Is it time to include cancer in cardiovascular risk prediction tools? by Blaes, Anne H, Shenoy, Chetan

“…Several new treatments, such as immunotherapy, tyrosine kinase inhibitors, proteasome inhibitors, and anti-oestrogen therapies, are known to cause endothelial…”
Get full text

Emotional health concerns of oncology physicians in the United States: Fallout during the COVID-19 pandemic by Thomaier, Lauren, Teoh, Deanna, Jewett, Patricia, Beckwith, Heather, Parsons, Helen, Yuan, Jianling, Blaes, Anne H, Lou, Emil, Hui, Jane Yuet Ching, Vogel, Rachel I

“…Cancer care is significantly impacted by the Coronavirus Disease 2019 (COVID-19) pandemic. Our objective was to evaluate the early effects of the pandemic on…”
Get full text

Shared Risk Factors in Cardiovascular Disease and Cancer by Koene, Ryan J, Prizment, Anna E, Blaes, Anne, Konety, Suma H

“…Cardiovascular disease (CVD) and cancer are the 2 leading causes of death worldwide. Although commonly thought of as 2 separate disease entities, CVD and…”
Get full text

Cancer Treatment-Induced Accelerated Aging in Cancer Survivors: Biology and Assessment by Wang, Shuo, Prizment, Anna, Thyagarajan, Bharat, Blaes, Anne

“…Rapid improvements in cancer survival led to the realization that many modalities used to treat or control cancer may cause accelerated aging in cancer…”
Get full text

Research contributions from the First Cancer Center Survivorship Research Forum by Blaes, Anne H.

Get full text

Cardiovascular Disease in Breast Cancer Survivors: An Important Topic in Breast Cancer Survivorship by Blaes, Anne H, Konety, Suma H

Get full text

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement by Herrmann, Joerg, Lenihan, Daniel, Armenian, Saro, Barac, Ana, Blaes, Anne, Cardinale, Daniela, Carver, Joseph, Dent, Susan, Ky, Bonnie, Lyon, Alexander R, López-Fernández, Teresa, Fradley, Michael G, Ganatra, Sarju, Curigliano, Giuseppe, Mitchell, Joshua D, Minotti, Giorgio, Lang, Ninian N, Liu, Jennifer E, Neilan, Tomas G, Nohria, Anju, O'Quinn, Rupal, Pusic, Iskra, Porter, Charles, Reynolds, Kerry L, Ruddy, Kathryn J, Thavendiranathan, Paaladinesh, Valent, Peter

“…Abstract The discipline of Cardio-Oncology has seen tremendous growth over the past decade. It is devoted to the cardiovascular (CV) care of the cancer…”
Get full text

Trastuzumab: Weighing the Benefits and the Risks by Blaes, Anne H, Dang, Chau

Get full text

The New Normal? Patient Satisfaction and Usability of Telemedicine in Breast Cancer Care by Johnson, Bryan A., Lindgren, Bruce R., Blaes, Anne H., Parsons, Helen M., LaRocca, Christopher J., Farah, Ronda, Hui, Jane Yuet Ching

“…Background Telemedicine was adopted to minimize exposure risks for patients and staff during the coronavirus disease 2019 pandemic. This study measured patient…”
Get full text

Accelerated Aging in Cancer Survivors: Cellular Senescence, Frailty, and Possible Opportunities for Interventions by Wang, Shuo, El Jurdi, Najla, Thyagarajan, Bharat, Prizment, Anna, Blaes, Anne H

“…The population of cancer survivors has markedly increased due to the rapid improvements in cancer treatment. However, cancer survivors experience accelerated…”
Get full text

Propranolol: What is BLOCKing Its Clinical Investigation in Breast Cancer? by Blaes, Anne H, Domingo-Musibay, Evidio, Kalinsky, Kevin

“…Presurgical propranolol modulates biomarkers associated with breast cancer progression. β-adrenergic signaling promotes invasion, epithelial-to-mesenchymal…”
Get full text

Multi-modality risk prediction of cardiovascular diseases for breast cancer cohort in the All of Us Research Program by Yang, Han, Zhou, Sicheng, Rao, Zexi, Zhao, Chen, Cui, Erjia, Shenoy, Chetan, Blaes, Anne H, Paidimukkala, Nishitha, Wang, Jinhua, Hou, Jue, Zhang, Rui

“…This study leverages the rich diversity of the All of Us Research Program (All of Us)'s dataset to devise a predictive model for cardiovascular disease (CVD)…”
Get full text

Psychological measures of stress and biomarkers of inflammation, aging, and endothelial dysfunction in breast cancer survivors on aromatase inhibitors by Blaes, Anne H., Nair, Chandini, Everson-Rose, Susan, Jewett, Patricia, Wolf, Jack, Zordoky, Beshay

“…The use of aromatase inhibitors (AIs) is associated with higher rates of cardiovascular events and lower endothelial function in breast cancer survivors…”
Get full text

Perspectives of cancer patients and their health during the COVID-19 pandemic by Lou, Emil, Teoh, Deanna, Brown, Katherine, Blaes, Anne, Holtan, Shernan G, Jewett, Patricia, Parsons, Helen, Mburu, E Waruiru, Thomaier, Lauren, Hui, Jane Yuet Ching, Nelson, Heather H, Vogel, Rachel I

“…The immunosuppressive nature of some cancers and many cancer-directed treatments may increase the risk of infection with and severe sequelae from Coronavirus…”
Get full text

The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up by Etteldorf, Andrew, Sedhom, Ramy, Rotolo, Shannon M., Vogel, Rachel I., Booth, Christopher M., Blaes, Anne H., Virnig, Beth A., Dusetzina, Stacie B., Gupta, Arjun

“…Purpose No single pharmacy in an urban zip code is consistently the least expensive across medications. If medication prices change differently across…”
Get full text

Estimated number of prevalent cases of metastatic bone disease in the US adult population by Li, Shuling, Peng, Yi, Weinhandl, Eric D, Blaes, Anne H, Cetin, Karynsa, Chia, Victoria M, Stryker, Scott, Pinzone, Joseph J, Acquavella, John F, Arneson, Thomas J

“…The prevalence of metastatic bone disease in the US population is not well understood. We sought to estimate the current number of US adults with metastatic…”
Get full text

Logistic burdens of cancer care: A qualitative study by Dona, Allison C, Jewett, Patricia I, Hwee, Sharon, Brown, Katherine, Solomon, Matia, Gupta, Arjun, Teoh, Deanna, Yang, Guang, Wolfson, Julian, Fan, Yingling, Blaes, Anne H, Vogel, Rachel I

“…Cancer treatment often creates logistic conflicts with everyday life priorities; however, these challenges and how they are subjectively experienced have been…”
Get full text

Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast by Marmor, Schelomo, Hui, Jane Yuet Ching, Huang, Jing Li, Kizy, Scott, Beckwith, Heather, Blaes, Anne H., Rueth, Natasha M., Tuttle, Todd M.

“…BACKGROUND Invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC) have distinct clinical, pathologic, and genomic characteristics. The objective…”
Get full text

Lessons From Primary Cardiac Prevention Trials During Trastuzumab Therapy by Barac, Ana, Blaes, Anne, Lynce, Filipa

Get full text

Price Comparison of Human and Veterinary Formulations of Common Medications by Haque, Waqas, Chencheri, Satheesh, Virnig, Beth A, Blaes, Anne H, Booth, Christopher M, Dusetzina, Stacie B, Gupta, Arjun

Get more information